1. Koyama K, Andou Y, Saruki K, Matsuo H. Delayed and severe toxicities of a herbicide containing glufosinate and a surfactant. Vet Hum Toxicol. 1994; 36:17–18.
2. Park HY, Lee PH, Shin DH, Kim GW. Anterograde amnesia with hippocampal lesions following glufosinate intoxication. Neurology. 2006; 67:914–915.
3. Lee HY, Song SY, Lee SH, Lee SY, Kim SH, Ryu SW. Vasogenic edema in striatum following ingestion of glufosinate-containing herbicide. J Clin Neurosci. 2009; 16:1372–1373.
4. Garcia-Monco JC, Cortina IE, Ferreira E, Martínez A, Ruiz L, Cabrera A, et al. Reversible splenial lesion syndrome (RESLES): what's in a name? J Neuroimaging. 2011; 21:e1–e14.
5. Nakaki T, Mishima A, Suzuki E, Shintani F, Fujii T. Glufosinate ammonium stimulates nitric oxide production through N-methyl D-aspartate receptors in rat cerebellum. Neurosci Lett. 2000; 290:209–212.
6. Moritani T, Smoker WR, Sato Y, Numaguchi Y, Westesson PL. Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR Am J Neuroradiol. 2005; 26:216–228.
7. Fujiki Y, Nakajima H, Ito T, Kitaoka H, Takahashi Y. [A case of clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with anti-glutamate receptor antibody]. Rinsho Shinkeigaku. 2011; 51:510–513.
8. Takahashi Y, Kubota Y, Yamasaki E, Matsuda K. [Rasmussen encephalitis and non-herpetic acute limbic encephalitis]. Rinsho Shinkeigaku. 2008; 48:163–172.
9. Pleasure D. Diagnostic and pathogenic significance of glutamate receptor autoantibodies. Arch Neurol. 2008; 65:589–592.
10. Watanabe T, Sano T. Neurological effects of glufosinate poisoning with a brief review. Hum Exp Toxicol. 1998; 17:35–39.